Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonsurf pharmacokinetic interaction study with metformin and cimetidine in metastatic colorectal cancer
NL-OMON20484Recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of trifluridine + tipiracil, metformin and cimetidine in colorectal cancer (CRC), sponsored by Erasmus MC. Primary endpoints: Lonsurf-metformin interaction on Lonsurf exposure and Lonsurf-cimetidine interaction on Lonsurf exposure. Started Oct 2019; status: recruiting.
02
Drugs
trifluridine + tipiracilmetformincimetidine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NL-OMON20484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20484.